A Comparison Between Biportal and Uniportal Endoscopic Lumbar Discectomy
Endoscopic Lumbar Discectomy: A Comparative Study Between Uniportal and Biportal Endocopic Techniques on Clinical and Surgical Outcomes
1 other identifier
interventional
60
1 country
1
Brief Summary
This study aims to provide a detailed comparison between different methods of lumbar discectomy by the use of different types of spine endoscopy to evaluate the benefits and drawbacks of each type
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedFirst Posted
Study publicly available on registry
September 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 1, 2027
September 3, 2025
August 1, 2025
1 year
August 19, 2025
August 25, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary outcome measures After endoscopic lumbar discectomy Pain relief
1-Pain Relief: Visual Analog Scale (VAS for leg and back pain)
12 weeks up to 2 years
Study Arms (1)
Patients with lumbar disc prolapse
ACTIVE COMPARATOR1. Patients aged 18-70 years. 2. single-level lumbar disc herniation (L3-L4, L4-L5, or L5-S1) confirmed by MRI. 3. Persistent symptoms not responding to conservative management (≥6 weeks).
Interventions
Uniportal and boportal endoscopic lumbar discectomy (transforaminal or interlaminar)
Eligibility Criteria
You may qualify if:
- All patients should fulfill the following criteria
- Patients aged 18-70 years.
- single-level lumbar disc herniation (L3-L4, L4-L5, or L5-S1) confirmed by MRI.
- Persistent symptoms not responding to conservative management (≥6 weeks).
You may not qualify if:
- All patients should not have any of the following criteria
- Multilevel disc herniation.
- Previous lumbar spine surgery, trauma or injection.
- Severe spinal stenosis.
- Severe osteoporosis, infection, or malignancy or autoimmune disease affecting the spine.
- Uncontrolled medical comorbidities contraindicating surgery.
- Instability: spondylolisthesis\>grade 1
- Marked obesity.(BMI \>35-40 kg/m2 )
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University
Sohag, Sohag Governorate, 002, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant lecturer at neurosurgery department sohag University
Study Record Dates
First Submitted
August 19, 2025
First Posted
September 3, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2027
Last Updated
September 3, 2025
Record last verified: 2025-08